Glyoxylate, a new marker metabolite of type 2 diabetes

Journal of Diabetes Research

Volumn 2014, Issue , 2014, Pages

  Nikiforova, Victoria J ^a,b   Giesbertz, Pieter ^c   Wiemer, Jan ^d,e   Bethan, Bianca ^d   Looser, Ralf ^d   Liebenberg, Volker ^a,e   Ruiz Noppinger, Patricia ^a,f   Daniel, Hannelore ^c   Rein, Dietrich ^a  

^a Metanomics Health GmbH   (Germany)

^b TIMIRYAZEV INSTITUTE OF PLANT PHYSIOLOGY   (Russian Federation)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d Metanomics GmbH   (Germany)

^e THERMO FISHER SCIENTIFIC   (Germany)

^f DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; GLUCOSE; GLYOXYLIC ACID; BIOLOGICAL MARKER; GLYOXYLIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD DONOR; BLOOD LEVEL; BLOOD SAMPLING; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DIABETOGENESIS; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE MODEL; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; MALE; MOUSE; MOUSE MODEL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PREDICTIVE VALUE; RETROSPECTIVE STUDY; ANIMAL; BLOOD; C57BL MOUSE; DIABETES MELLITUS, TYPE 2; DIET RESTRICTION; GENETICS; GENOTYPE; METABOLISM; METABOLOMICS; PHENOTYPE; PROCEDURES; PROSPECTIVE STUDY; SKELETAL MUSCLE; TIME FACTOR; UPREGULATION;

ANIMALS; BIOMARKERS; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; FASTING; GENOTYPE; GLYOXYLATES; HUMANS; MALE; METABOLOMICS; MICE, INBRED C57BL; MUSCLE, SKELETAL; PHENOTYPE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; TIME FACTORS; UP-REGULATION;

EID: 84915747811     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2014/685204     Document Type: Article

References (60)

1. Nguyen D. V., Shaw L. C., Grant M. B., Inflammation in the pathogenesis of microvascular complications in diabetes. Frontiers in Endocrinology 2012 3, article 170 10.3389/fendo.2012.00170
2. Gorbachinsky I., Akpinar H., Assimos D. G., Metabolic syndrome and urologic diseases. Reviews in Urology 2010 12 e157 e180
3. Fiehn O., Garvey W. T., Newman J. W., Lok K. H., Hoppel C. L., Adams S. H., Plasma metabolomic profiles reflective of glucose homeostasis in non-diabetic and type 2 diabetic obese African-American women. PLoS ONE 2010 5 12 e15234 2-s2.0-78650732495 10.1371/journal.pone.0015234
4. Lanza I. R., Zhang S., Ward L. E., Karakelides H., Raftery D., Nair K. S., Quantitative metabolomics by 1H-NMR and LC-MS/MS confirms altered metabolic pathways in diabetes. PLoS ONE 2010 5 5 e10538 10.1371/journal.pone.0010538 2-s2.0-77956276702
5. Suhre K., Meisinger C., Döring A., Altmaier E., Belcredi P., Gieger C., Chang D., Milburn M. V., Gall W. E., Weinberger K. M., Mewes H.-W., Angelis M. H., Wichmann H.-E., Kronenberg F., Adamski J., Illig T., Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting. PLoS ONE 2010 5 11 e13953 2-s2.0-78649735772 10.1371/journal.pone.0013953
6. Roberts L. D., Koulman A., Griffin J. L., Towards metabolic biomarkers of insulin resistance and type 2 diabetes: progress from the metabolome. The Lancet Diabetes & Endocrinology 2014 2 1 65 75 10.1016/S2213-8587(13)70143-8 2-s2.0-84890207090
7. Wang-Sattler R., Yu Z., Herder C., Messias A. C., Floegel A., He Y., Heim K., Campillos M., Holzapfel C., Thorand B., Grallert H., Xu T., Bader E., Huth C., Mittelstrass K., Döring A., Meisinger C., Gieger C., Prehn C., Roemisch-Margl W., Carstensen M., Xie L., Yamanaka-Okumura H., Xing G., Ceglarek U., Thiery J., Giani G., Lickert H., Lin X., Li Y., Boeing H., Joost H.-G., De Angelis M. H., Rathmann W., Suhre K., Prokisch H., Peters A., Meitinger T., Roden M., Wichmann H.-E., Pischon T., Adamski J., Illig T., Novel biomarkers for pre-diabetes identified by metabolomics. Molecular Systems Biology 2012 8, article 615 10.1038/msb.2012.43 2-s2.0-84867012919
8. Floegel A., Stefan N., Yu Z., Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes 2013 62 2 639 648 10.2337/db12-0495 2-s2.0-84873042769
9. Wang T. J., Ngo D., Psychogios N., Dejam A., Larson M. G., Vasan R. S., Ghorbani A., O'Sullivan J., Cheng S., Rhee E. P., Sinha S., McCabe E., Fox C. S., O'Donnell C. J., Ho J. E., Florez J. C., Magnusson M., Pierce K. A., Souza A. L., Yu Y., Carter C., Light P. E., Melander O., Clish C. B., Gerszten R. E., 2-Aminoadipic acid is a biomarker for diabetes risk. Journal of Clinical Investigation 2013 123 10 4309 4317 10.1172/JCI64801 2-s2.0-84885031125
10. Sailer M., Dahlhoff C., Giesbertz P., Increased plasma citrulline in mice marks diet-induced obesity and may predict the development of the metabolic syndrome. PLoS ONE 2013 8 5 e63950 2-s2.0-84877758478 10.1371/journal.pone.0063950
11. Padberg I., Peter E., González-Maldonado S., Witt H., Mueller M., Weis T., Bethan B., Liebenberg V., Wiemer J., Katus H. A., Rein D., Schatz P., A new metabolomic signature in type-2 diabetes mellitus and its pathophysiology. PLoS ONE 2014 9 1 e85082 2-s2.0-84898406508 10.1371/journal.pone.0085082
12. Clarke H. T., Henry drysdale dakin, 1880-1952. The Journal of Biological Chemistry 1952 198 2 491 494 2-s2.0-33744515719
13. Ratner S., Nocito V., Green D. E., Glycine oxidase. The Journal of Biological Chemistry 1944 152 119 133
14. Kun E., A study on the metabolism of glyoxal in vitro. The Journal of Biological Chemistry 1952 194 2 603 611 2-s2.0-34548461613
15. Richardson K. E., Tolbert N. E., Oxidation of glyoxylic acid to oxalic acid by glycolic acid oxidase. The Journal of Biological Chemistry 1961 236 1280 1284 2-s2.0-0000889768
16. Sawaki S., Yamada K., Glyoxylate reductase activity of lactate dehydrogenase. Nature 1966 210 31 91 2-s2.0-0014003921
17. Mardashev S. B., Semina L. A., Enzymic synthesis of glycine from glyoxalic acid. Doklady Akademii Nauk SSSR 1950 74 537 540
18. Song S., Can the glyoxylate pathway contribute to fat-induced hepatic insulin resistance? Medical Hypotheses 2000 54 739 747 10.1054/mehy.1999.0943
19. Hummel K. P., Dickie M. M., Coleman D. L., Diabetes, a new mutation in the mouse. Science 1966 153 3740 1127 1128 10.1126/science.153.3740.1127 2-s2.0-0014004384
20. American Diabetes Association, Standards of medical care in diabetes-2010. Diabetes Care 2010 33 supplement 1 S11 S61
21. Allaway D., Kamlage B., Gilham M. S., Hewson-Hughes A. K., Wiemer J. C., Colyer A., Rein D., Effects of dietary glucose supplementation on the fasted plasma metabolome in cats and dogs. Metabolomics 2013 9 5 1096 1108 10.1007/s11306-013-0527-8 2-s2.0-84884416182
22. Kim W. J., Park C. Y., 1,5-Anhydroglucitol in diabetes mellitus. Endocrine 2013 43 1 33 40 10.1007/s12020-012-9760-6
23. Eppinger H., Fate of glyoxylic acid in the animal organism. Beiträge Chemischen Physiologie Pathologie 1905 6 492 501
24. Dakin H. D., Experiments bearing upon the mode of oxidation of simple aliphatic substances in the animal organism. The Journal of Biological Chemistry 1907 152 57 79
25. Hoppe B., An update on primary hyperoxaluria. Nature Reviews Nephrology 2012 8 467 475 10.1038/nrneph.2012.113
26. Belostotsky R., Seboun E., Idelson G. H., Milliner D. S., Becker-Cohen R., Rinat C., Monico C. G., Feinstein S., Ben-Shalom E., Magen D., Weissman I., Charon C., Frishberg Y., Mutations in DHDPSL are responsible for primary hyperoxaluria type III. The American Journal of Human Genetics 2010 87 3 392 399 10.1016/j.ajhg.2010.07.023 2-s2.0-77956393040
27. Knight J., Assimos D. G., Easter L., Holmes R. P., Metabolism of fructose to oxalate and glycolate. Hormone and Metabolic Research 2010 42 12 868 873 10.1055/s-0030-1265145 2-s2.0-78249246055
28. Neims A. H., Hellerman L., Specificity of the D-amino acid oxidase in relation to glycine oxidase activity. The Journal of biological chemistry 1962 237 C976 C978 2-s2.0-9044251179
29. Baker P. R. S., Cramer S. D., Kennedy M., Assimos D. G., Holmes R. P., Glycolate and glyoxylate metabolism in HepG2 cells. American Journal of Physiology: Cell Physiology 2004 287 5 C1359 C1365 10.1152/ajpcell.00238.2004 2-s2.0-6044252406
30. Schnedler N., Burckhardt G., Burckhardt B. C., Glyoxylate is a substrate of the sulfate-oxalate exchanger, sat-1, and increases its expression in HepG2 cells. Journal of Hepatology 2011 54 3 513 520 10.1016/j.jhep.2010.07.036 2-s2.0-79951678320
31. Marengo S. R., Romani A. M., Oxalate in renal stone disease: the terminal metabolite that just won't go away. Nature Clinical Practice Nephrology 2008 4 368 377 10.1038/ncpneph0845
32. Piarulli F., Sartore G., Lapolla A., Glyco-oxidation and cardiovascular complications in type 2 diabetes: a clinical update. Acta Diabetologica 2013 50 2 101 110 10.1007/s00592-012-0412-3 2-s2.0-84878260579
33. Lapolla A., Porcu S., Traldi P., Some views on proteomics in diabetes. Clinical Chemistry and Laboratory Medicine 2011 49 6 943 957 10.1515/CCLM.2011.151 2-s2.0-79958251808
34. Thornalley P. J., Langborg A., Minhas H. S., Formation of glyoxal, methylglyoxal and 8-deoxyglucosone in the glycation of proteins by glucose. Biochemical Journal 1999 344 1 109 116 2-s2.0-0033571012 10.1042/0264-6021:3440109
35. Thornalley P., Wolff S., Crabbe J., Stern A., The autoxidation of glyceraldehyde and other simple monosaccharides under physiological conditions catalysed by buffer ions. Biochimica et Biophysica Acta-General Subjects 1984 797 2 276 287 10.1016/0304-4165(84)90131-4 2-s2.0-0021361665
36. Wolff S. P., Dean R. T., Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes. Biochemical Journal 1987 245 1 243 250 2-s2.0-0023259759
37. Ahmed N., Babaei-Jadidi R., Howell S. K., Beisswenger P. J., Thornalley P. J., Degradation products of proteins damaged by glycation, oxidation and nitration in clinical type 1 diabetes. Diabetologia 2005 48 8 1590 1603 10.1007/s00125-005-1810-7 2-s2.0-22444447985
38. Fu M.-X., Requena J. R., Jenkins A. J., Lyons T. J., Baynes J. W., Thorpe S. R., The advanced glycation end product, Nε -(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions. The Journal of Biological Chemistry 1996 271 17 9982 9986 10.1074/jbc.271.17.9982 2-s2.0-0029923574
39. Loidl-Stahlhofen A., Spiteller G., α -hydroxyaldehydes, products of lipid peroxidation. Biochimica et Biophysica Acta-Lipids and Lipid Metabolism 1994 1211 2 156 160 10.1016/0005-2760(94)90264-X 2-s2.0-0028175131
40. Mlakar A., Spiteller G., Previously unknown aldehydic lipid peroxidation compounds of arachidonic acid. Chemistry and Physics of Lipids 1996 79 1 47 53 2-s2.0-0030054125 10.1016/0009-3084(95)02506-5
41. Benov L., Fridovich I., Superoxide dependence of the toxicity of short chain sugars. The Journal of Biological Chemistry 1998 273 40 25741 25744 10.1074/jbc.273.40.25741 2-s2.0-0032476044
42. Glomb M. A., Monnier V. M., Mechanism of protein modification by glyoxal and glycolaldehyde, reactive intermediates of the Maillard reaction. Journal of Biological Chemistry 1995 270 17 10017 10026 10.1074/jbc.270.17.10017 2-s2.0-0028934990
43. Conyers R. A. J., Bais R., Rofe A. M., The relation of clinical catastrophes, endogenous oxalate production, and urolithiasis. Clinical Chemistry 1990 36 10 1717 1730 2-s2.0-0025013875
44. Turk Z., Glycotoxines, carbonyl stress and relevance to diabetes and its complications. Physiological Research 2010 59 2 147 156 2-s2.0-77953934812
45. Dutta U., Cohenford M. A., Guha M., Dain J. A., Non-enzymatic interactions of glyoxylate with lysine, arginine, and glucosamine: a study of advanced non-enzymatic glycation like compounds. Bioorganic Chemistry 2007 35 1 11 24 10.1016/j.bioorg.2006.07.005 2-s2.0-33846229270
46. Schmitt A., Schmitt J., Münch G., Gasic-Milencovic J., Characterization of advanced glycation end products for biochemical studies: side chain modifications and fluorescence characteristics. Analytical Biochemistry 2005 338 2 201 215 10.1016/j.ab.2004.12.003
47. Matsumura Y., Iwasawa A., Kobayashi T., Kamachi T., Ozawa T., Kohno M., The reactivity of α -oxoaldehyde with reactive oxygen species in diabetes complications. Journal of Clinical Biochemistry and Nutrition 2013 52 2 128 132 2-s2.0-84875884102 10.3164/jbcn.12-70
48. Dakin H. D., Dudley H. W., An enzyme concerned with the formation of hydroxy acids from ketonic aldehydes. The Journal of Biological Chemistry 1913 14 155 157
49. Thornalley P. J., The glyoxalase system in health and disease. Molecular Aspects of Medicine 1993 14 4 287 371 2-s2.0-0027454552 10.1016/0098-2997(93)90002-U
50. Thornalley P. J., Glutathione-dependent detoxification of α -oxoaldehydes by the glyoxalase system: involvement in disease mechanisms and antiproliferative activity of glyoxalase I inhibitors. Chemico-Biological Interactions 1998 111-112 137 151 2-s2.0-4244040278 10.1016/S0009-2797(97)00157-9
51. Baba S. P., Barski O. A., Ahmed Y., Reductive metabolism of AGE precursors: a metabolic route for preventing AGE accumulation in cardiovascular tissue. Diabetes 2009 58 11 2486 2497 10.2337/db09-0375 2-s2.0-70350543787
52. van der Jagt D. L., Hunsaker L. A., Young B. S., Brown W. M., Aldo-keto reductase-catalyzed detoxication of endogenous aldehydes associated with diabetic complications. ACS Symposium Series 2003 865 23 35 10.1021/bk-2003-0865.ch002 2-s2.0-81855209866
53. Kraemer R. J., Deitrich R. A., Isolation and characterization of human liver aldehyde dehydrogenase. Journal of Biological Chemistry 1968 243 24 6402 6408 2-s2.0-0014430406
54. Rabbani N., Thornalley P. J., The critical role of methylglyoxal and glyoxalase 1 in diabetic nephropathy. Diabetes 2014 63 1 50 52 10.2337/db13-1606 2-s2.0-84891816601
55. Beisswenger P. J., Howell S. K., Russell G. B., Miller M. E., Rich S. S., Mauer M., Early progression of diabetic nephropathy correlates with methylglyoxal-derived advanced glycation end products. Diabetes Care 2013 36 10 3234 3239 10.2337/dc12-2689 2-s2.0-84888108332
56. Arora M. K., Singh U. K., Molecular mechanisms in the pathogenesis of diabetic nephropathy: an update. Vascular Pharmacology 2013 58 259 271 10.1016/j.vph.2013.01.001
57. Taylor E. N., Curhan G. C., Determinants of 24-hour urinary oxalate excretion. Clinical Journal of the American Society of Nephrology 2008 3 5 1453 1460 10.2215/CJN.01410308
58. Eisner B. H., Porten S. P., Bechis S. K., Stoller M. L., Diabetic kidney stone formers excrete more oxalate and have lower urine pH than nondiabetic stone formers. The Journal of Urology 2010 183 6 2244 2248 10.1016/j.juro.2010.02.007 2-s2.0-77951878095
59. Kadlec A. O., Greco K., Fridirici Z. C., Hart S. T., Vellos T., Turk T. M., Metabolic syndrome and urinary stone composition: what factors matter most? Urology 2012 80 4 805 810 10.1016/j.urology.2012.05.011 2-s2.0-84866743561
60. Cho S. T., Jung S. I., Myung S. C., Kim T. H., Correlation of metabolic syndrome with urinary stone composition. International Journal of Urology 2013 20 208 213 10.1111/j.1442-2042.2012.03131.x